Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 1
2006 2
2007 4
2009 3
2010 3
2011 2
2012 2
2014 3
2015 4
2016 4
2017 1
2018 3
2021 4
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model.
Siemionow M, Budzynska K, Zalants K, Langa P, Brodowska S, Siemionow K, Heydemann A. Siemionow M, et al. Among authors: heydemann a. Biomedicines. 2024 Mar 6;12(3):586. doi: 10.3390/biomedicines12030586. Biomedicines. 2024. PMID: 38540201 Free PMC article.
Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic-Intraosseous Administration.
Niezgoda A, Biegański G, Wachowiak J, Czarnota J, Siemionow K, Heydemann A, Ziemiecka A, Sikorska MH, Bożyk K, Siemionow M. Niezgoda A, et al. Among authors: heydemann a. Arch Immunol Ther Exp (Warsz). 2023 Nov 24;71(1):24. doi: 10.1007/s00005-023-00691-y. Arch Immunol Ther Exp (Warsz). 2023. PMID: 37999748 Free PMC article.
Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration.
Siemionow M, Biegański G, Niezgoda A, Wachowiak J, Czarnota J, Siemionow K, Ziemiecka A, Sikorska MH, Bożyk K, Heydemann A. Siemionow M, et al. Among authors: heydemann a. Stem Cell Rev Rep. 2023 Nov;19(8):2724-2740. doi: 10.1007/s12015-023-10620-3. Epub 2023 Sep 14. Stem Cell Rev Rep. 2023. PMID: 37707670 Free PMC article.
Intraosseous transplant of dystrophin expressing chimeric (DEC) cells improves skeletal muscle function in mdx mouse model of Duchenne muscular dystrophy.
Malik M, Siemionow M, Cwykiel J, Heydemann A, Garcia-Martinez J, Siemionow K, Szilagyi E. Malik M, et al. Among authors: heydemann a. Postepy Kardiol Interwencyjnej. 2022 Dec;18(4):399-406. doi: 10.5114/aic.2021.110990. Epub 2021 Nov 20. Postepy Kardiol Interwencyjnej. 2022. PMID: 36967847 Free PMC article.
Correction: Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A. Siemionow M, et al. Among authors: heydemann a. Stem Cell Rev Rep. 2023 Feb;19(2):582-583. doi: 10.1007/s12015-022-10472-3. Stem Cell Rev Rep. 2023. PMID: 36441490 Free PMC article. No abstract available.
Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.
Siemionow M, Brodowska S, Langa P, Zalants K, Kozlowska K, Grau-Kazmierczak W, Heydemann A. Siemionow M, et al. Among authors: heydemann a. Arch Immunol Ther Exp (Warsz). 2022 Aug 17;70(1):20. doi: 10.1007/s00005-022-00656-7. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35978142 Free PMC article.
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A. Siemionow M, et al. Among authors: heydemann a. Stem Cell Rev Rep. 2022 Dec;18(8):2872-2892. doi: 10.1007/s12015-022-10384-2. Epub 2022 May 19. Stem Cell Rev Rep. 2022. PMID: 35590083 Free PMC article.
43 results